Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.
- Address
- lock Available on a paid plan
Immune System Diseases and Rheumatology
At Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o., clinical research in immune system diseases focuses on inflammatory conditions such as rheumatoid arthritis and axial spondyloarthritis. These studies are designed to assess whether new treatments can better reduce symptoms and improve everyday function for people living with chronic autoimmune disease.
- Evaluating new options for rheumatoid arthritis symptom control and disease activity
- Studying treatment effects in axial spondyloarthritis to improve signs and symptoms
- Advancing care for autoimmune and rheumatic diseases through targeted therapy research
The research here aims to compare emerging therapies with placebo and determine whether they offer meaningful improvements in inflammation, pain, and overall disease control.
Skin and Connective Tissue Diseases
Dermatology trials at this site include studies in atopic dermatitis and dermatomyositis, two conditions that can significantly affect comfort, skin health, and quality of life. The research is centered on testing whether newer treatments can more effectively reduce disease severity and improve visible symptoms.
- Investigating therapies for atopic dermatitis to improve eczema signs and skin clearance
- Assessing treatment benefit in dermatomyositis with a focus on overall improvement
- Supporting research into connective tissue diseases with potential impact on skin and muscle involvement
These studies help determine whether investigational medicines can offer better symptom relief and disease control for patients with challenging inflammatory skin and muscle disorders.
Musculoskeletal Diseases
The site also contributes to research in musculoskeletal diseases, with a particular focus on conditions that affect joints, muscles, and mobility. This includes work across arthritis, joint diseases, and broader rheumatic diseases, where the goal is to understand how new therapies may improve physical function and reduce inflammation.
- Examining treatment effectiveness in arthritis and related joint disorders
- Exploring approaches that may improve mobility and daily activity in musculoskeletal diseases
- Building evidence for better management of chronic rheumatic and inflammatory conditions
Overall, the clinical trials at this hospital/clinic are aimed at strengthening treatment options across inflammatory skin, muscle, and joint diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eli Lilly & Co.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis | Alfasigma S.p.A. | Phase III | Not Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Brepocitinib Tosilate | 1 | Unknown | 2022-11-30 | 2022-11-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.